...
首页> 外文期刊>Current pharmaceutical design >Application of Artificial Intelligence in Pharmaceutical and Biomedical Studies
【24h】

Application of Artificial Intelligence in Pharmaceutical and Biomedical Studies

机译:人工智能在制药和生物医学研究中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Artificial intelligence (AI) is the way to model human intelligence to accomplish certain tasks without much intervention of human beings. The term AI was first used in 1956 with The Logic Theorist program, which was designed to simulate problem-solving ability of human beings. There have been a significant amount of research works using AI in order to determine the advantages and disadvantages of its applicabication and, future perspectives that impact different areas of society. Even the remarkable impact of AI can be transferred to the field of healthcare with its use in pharmaceutical and biomedical studies crucial for the socioeconomic development of the population in general within different studies, we can highlight those that have been conducted with the objective of treating diseases, such as cancer, neurodegenerative diseases, among others. In parallel the long process of drug development also requires the application of AI to accelerate research in medical care.
机译:背景:人工智能(AI)是模拟人类智力的方式,以完成某些任务而没有人类的干预。 术语AI首先于1956年使用了逻辑理论课程计划,旨在模拟人类的问题解决能力。 使用AI已经有大量的研究作品,以确定其应用的优缺点,并影响社会不同领域的未来观点。 即使是AI的显着影响也可以通过其在医药和生物医学研究中转移到医疗保健领域,其在不同研究中的人口的社会经济发展至关重要,我们可以强调那些已经通过治疗疾病的目标进行的人 ,例如癌症,神经变性疾病等。 在并行中,药物发育的长途过程还需要AI在医疗保健中加速研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号